alexa Michel Goldman | Innovative Medicines Initiative
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Michel Goldman

Innovative Medicines Initiative
Michel Goldman, MD, PhD, is Full Professor at the Université Libre de Bruxelles where he is the Founder of the I3h Institute for Interdisciplinary Innovation in healthcare.He has been awarded the Highly Cited Scientist recognition by the Thomson Institute for Scientific Information in the year 2006. He has also receiived the Spinoza Chair at the University of Amsterdam in the year 2001.
Research Interest

Pharmaceutical,IndustryEuropean, UnionLifesciences, Immunology,Infectious Diseases, Science Clinical Research ,MedicineTransplant, Molecular Biology, Neuroscience Government


Data Standards are Needed to Move Translational Medicine Forward

Ann Marie Martin, Nathalie Seigneuret, Ferran Sanz and Michel Goldman

Commentary: Transl Med 2013, 3: 119

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version